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Abstract
Background: Microinsurance or Community-Based Health Insurance is a promising healthcare financing mechanism,
which is increasingly applied to aid rural poor persons in low-income countries. Robust empirical evidence on the
causal relations between Community-Based Health Insurance and healthcare utilisation, financial protection and other
areas is scarce and necessary. This paper contains a discussion of the research design of three Cluster Randomised
Controlled Trials in India to measure the impact of Community-Based Health Insurance on several outcomes.
Methods/Design: Each trial sets up a Community-Based Health Insurance scheme among a group of micro-finance
affiliate families. Villages are grouped into clusters which are congruous with pre-existing social groupings. These
clusters are randomly assigned to one of three waves of implementation, ensuring the entire population is offered
Community-Based Health Insurance by the end of the experiment. Each wave of treatment is preceded by a round of
mixed methods evaluation, with quantitative, qualitative and spatial evidence on impact collected. Improving upon
practices in published Cluster Randomised Controlled Trial literature, we detail how research design decisions have
ensured that both the households offered insurance and the implementers of the Community-Based Health Insurance
scheme operate in an environment replicating a non-experimental implementation.
Discussion: When a Cluster Randomised Controlled Trial involves randomizing within a community, generating
adequate and valid conclusions requires that the research design must be made congruous with social structures
within the target population, to ensure that such trials are conducted in an implementing environment which is a
suitable analogue to that of a non-experimental implementing environment.
Keywords: Micro insurance, community based, healthcare utilisation, financial protection, randomised trial
Background and Rationale
Background
Health insurance coverage is woefully lacking in the devel-
oping world. Poor households must often resort to high-
cost loans or asset sales to finance healthcare, and may be
forced to forego essential treatments altogether (Binnedijk
E, et al, Hardship financing of healthcare among rural
poor in Orissa, India, submitted). Development organisa-
t i o n sh a v ei n c r e a s i n g l yr e c o g n i s e dt h er o l et h a th e a l t h
microinsurance (HMI) can play as a poverty reduction
tool [1,2]. One form of HMI is Community-Based Health
Insurance (CBHI), in which communities mutualise risks
and resources into a locally-managed healthcare fund [3].
CBHI schemes have been implemented in India, Afghani-
stan, Nepal, Burkina Faso, Mali, Senegal, Nigeria, and
extensively throughout Rwanda and Tanzania. However,
recent literature reviews have noted both a limited body of
evidence on both HMI and CBHI impact, and consider-
able methodological problems in many of the available
studies [4-6].
To help close knowledge gaps and aid policy design,
Erasmus University Rotterdam, the University of Cologne
and the Micro Insurance Academy (MIA) are operating
three separate CBHI impact evaluations in rural areas of
northern India. The microinsurance schemes are being
implemented by three Indian charitable NGOs (BAIF,
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MIA. Each evaluation is organised as a cluster randomised
controlled trial (CRCT), in which randomly selected mem-
bers of a network of women’s microfinance groups (“Self
Help Groups” or SHGs) are offered the option to affiliate
to a CBHI scheme which they design and manage. The
impact of each scheme on a range of indicators will be
analysed, including healthcare utilisation and financial
protection of members.
This article describes the study protocol of these trials,
with a focus on the issues faced in designing a methodolo-
gically robust CRCT that must also meet the constraints
imposed by implementation requirements. Scientific eva-
luations of development programs must always take place
in a specific context, with the result that the institutional
setting and implementation needs of the program can
influence both the internal and external validity of analyses
of its impact. The article details how implementation con-
straints impacted research design, and how research and
implementation needs were jointly considered prior to
launching the project, in order to ensure both a supportive
and scientifically robust trial environment.
Rationale
The crucial issue in measuring the impact of CBHI is the
construction of a comparable and unbiased counter-fac-
tual. Let Yi be annual health care use in a village i that is
offered the opportunity to enroll in a CBHI scheme. The
village has two potential outcomes; its annual health care
use if it avails of CBHI (treated, or yit) and its annual
health care use if it does not (control, or yic). The treat-
ment effect of CBHI on annual village level health care use
equals yit-yic; but only one of the potential outcomes can
be observed, as a single village cannot simultaneously be
insured and uninsured. If multiple villages are observed,
some which avail of CBHI and others which do not, an
estimate of the expected treatment effect, E(yit-yic), can be
recovered by measuring the difference between them,
(Yt-Yc). For this to provide unbiased estimates, the villages
that take up CBHI must be comparable, both in observa-
ble and unobservable characteristics, to those which do
not. However, in the context of a voluntary insurance pro-
gram, those villages which take up CBHI are likely to be
richer, sicker, or otherwise systematically different from
those which do not. The effects of these selection biases
over treatment and control groups, B, means the measured
effect of CBHI is (Yt-Yc) = E(yit-yic)+B.
One way to avoid this problem is by randomising villages
into treatment and control groups. Cluster randomised
controlled trials (also known as “Group Randomised
Trials”), ensure an unbiased counterfactual by explicitly
randomising treatment over clusters of individuals. In the
above context, the treatment is the offer of CBHI, and the
groups/clusters are villages. As external variables are
blocked from influencing selection into treatment and con-
trol groups, the outcomes of villages randomly assigned to
the control group are the same in expectation as the out-
comes the treatment group would have experienced had
they remained untreated i.e. E(B) = 0. The measured treat-
ment effect, (Yt-Yc), is thus an unbiased estimate of the
mean treatment effect, E(yit-yic) [7,8]*. For this reason, ran-
domised trials are generally considered the “gold standard”
in quantitative impact evaluations [9].
Unfortunately, by this standard, the quantitative knowl-
edge base on the impact of CBHI is methodologically
weak, as well as limited in scope. We are aware of only 6
CBHI schemes which have been subject to quantitative
evaluations employing regressions or more rigorous
methods. Only 1 scheme has been evaluated by CRCT
[10], with 2 other schemes having been evaluated using a
less rigorous quasi-experimental approach [11]. The
remaining 3 schemes have been evaluated only via regres-
sion-based methodologies [12-14], which cannot control
for unobservable differences between insured and unin-
sured populations, and are therefore likely to deliver
biased impact estimates. The body of available evidence
on CBHI impact is too small and methodologically weak
to make any general conclusions. Moreover, these six
evaluations each utilise different indicators to measure
the impact of CBHI, which causes considerable difficul-
ties in making cross-study comparisons of impact.
The motivation for the three CRCTs described in this
paper is to help close these knowledge gaps: to provide
reliable quantitative evidence on CBHI impact by employ-
ing the CRCT approach; to quickly upscale the number of
CBHI trials which have been evaluated by running three
separate trials; and to begin generating evidence which is
comparable across trials by using standard data collection
tools and outcome indicators.
Methods
All three CRCTs follow the same research protocol. Pre-
defined clusters of individuals are randomly assigned to
either treatment or control groups. Those in the treat-
ment clusters take part in a structured education pro-
gram on insurance and CBHI, participate in package
design and pricing decisions, and are then offered the
option to pay a premium and join the CBHI scheme.
Those paying the premium enjoy pre-defined health
insurance benefits for one year. Those in control clus-
ters are offered neither insurance education nor CBHI
membership. Three waves of implementation sequen-
tially roll out treatment to all clusters over time. The
following discussion focuses on how the research proto-
col has been pro-actively developed to take into account
implementation considerations.
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Page 2 of 15Location, Implementing Partners & Target Population
The three CRCTs are being undertaken at three separate
sites in Northern India - one each in Kanpur Dehat and
Pratapgarh districts in Uttar Pradesh, and one in Vaishali
district in Bihar (Figure 1). All three sites are poor rural
areas primarily dependent on agriculture, located 50-100
km outside major urban centers.
Implementation of a CBHI scheme pre-supposes that
the trial region contains a self-identified community,
with experience of co-operating democratically for
mutual benefit, and an apex body within this community
capable of driving new social programs. At each trial,
implementation is thus facilitated by a locally based
NGO, or “implementing partner”. Each implementing
partner oversees a pre-existing network of Self Help
Groups (SHGs) in the project area. SHGs typically con-
sist of a group of 10-20 women from a village, who agree
to add a pre-specified amount of money to a communal
pot/bank account each month. Members may take loans
from the pot for investment activities and emergency
expenditures. The SHG concept originated in India in
the 1980s as a self-contained alternative to government
sponsored co-operative societies [15]. The number of
SHGs has grown steadily since the early 1990’s, and
groups are now found throughout India [16]. In 2009,
over 1.6 million functioning SHGs were affiliated with
formal-sector banks [17]. Implementing partners for our
CBHI project were purposively selected on the basis of
an evaluation of their capacity to provide support to their
SHGs during the insurance set-up process
† .
At each site, the experimental cohort is defined as all
members of households with at least one woman regis-
tered in March 2010 as a member of an SHG facilitated by
the local implementing partner. Totals of 8933, 7105 and
7838 persons are eligible to take part in the experiment at
Pratapgarh, Kanpur Dehat and Vaishali respectively. Table
1 presents summary statistics of those eligible to partici-
pate in the trial (based on data from the baseline survey -
see below). The average daily consumption per person (in
purchasing power parity $, including home produced
food) is estimated at $2.72 (Pratapgarh), $3.05 (Vaishali)
and $4.17 (Kanpur Dehat). Respectively, 26%, 18% and
23% of households report themselves as being below the
international absolute poverty line of PPP $1.25 per person
per day. The majority of adult males work in agriculture,
either farming their own small holdings or working as
casual labourers on others’ land. At Pratapgarh and
Vaishali, which include some small rural town areas, 19%-
20% of adult males work in a small business, such as road-
side vending. In Kanpur Dehat, 70% of all adult males
work in agriculture, and only 12% work in any form of
business. At all sites, most adult females attend to domes-
tic duties for their households. Healthcare access is poor:
as is common in India, when a new illness develops, at
least half of first-contact outpatient visits at all three sites
are to unqualified providers [18].
Description of treatment program
The treatment on these CRCTs is a CBHI implementation
program which has been developed by the Micro Insur-
ance Academy. The MIA is an Indian-based charitable
trust which provides research, training, structured techni-
cal assistance, and advisory services to CBHI and other
microinsurance programs. In a CBHI scheme, a local com-
munity owns and operates a health insurance fund on a
not-for-profit basis. Community members are involved in
Trial 2 - 
Kanpur 
Dehat 
Trial 1 - 
Pratapgarh 
Trial 3 - 
Vaishali 
Uttar Pradesh 
Bihar 
Figure 1 Locations of Trial Sites.
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Trial 1 - Pratapgarh Trial 2 -
Kanpur Dehat
Trial 3 - Vaishali
State Uttar Pradesh Uttar Pradesh Bihar
Implementing Partner BAIF Shramik Bharti Nidan
No. Villages 15 42 34
Trial Population* 8933 7105 7838
No. SHG Members 1557 1226 1459
Mean Annual Consumption per capita Rs (Standard Deviation) 16233 (15131) 24934 (30298) 18231 (21772)
Mean Annual Consumption per capita $US (Standard Deviation)** 358 (334) 551 (669) 403 (481)
Mean Consumption, per capita per annum, $PPP (Standard Deviation)*** 991 (924) 1523 (1850) 1113 (1329)
Mean Daily Consumption per capita, $PPP (Standard Deviation) 2.72 (2.53) 4.17 (5.07) 3.05 (3.64)
% of HHs below International Absolute Poverty Line (PPP “tabcaption”.25 at 2005 prices) 26 18 23
% Adult Males in Agriculture 53 70 59
% Adult Females at Home 65 70 67
% First Visits to Unqualified Providers 55 67 50
* Estimate - Number of SHG members is known, but not all SHG members answered a HH survey, so size of all households is not known. Estimate = [(No. of SHG members who did not answer HH survey) ×
(average HH size at site)] + [No. people in HHs of SHG members who answered HH survey]
** Calculated at USD/Rupee midrate of 1/45.29, Dec 3 2010
*** Calculated at World Bank PPP conversion factor for 2009 of 0.3616
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5package design and pricing decisions, and ideally elect/
nominate members to act as administrative staff. Any
profits are retained as capital buffers, or returned to mem-
bers. The particular CBHI implementation model used is
based on the MIA’s extensive field experience in the set-
up of CBHI schemes, and has previously been rolled-out
in full at four sites, two in India and two in Nepal.
Although it has proven successful in establishing CBHI
schemes among low income persons with little or no prior
experience of insurance, this model’s impact on access to
care and financial protection has not previously been the
subject of rigorous evaluation. The model consists of a
sequence of four self-contained modules (Figure 2). To aid
generalisability of findings, and comparisons across the
three trials, each module is defined by function (the pur-
pose it seeks to achieve) rather than content (the specific
manner in which this purpose is achieved) [19]. The
sequencing and time span of each module is homogeneous
across sites, but content and operations are subject to
(usually minor) context specific modifications.
Implementation begins with a “Design” module, which
optimises the contents and operation of the CBHI scheme,
2. Awareness 
Awareness Campaign (x3) 
CHAT (x2) 
Enrollment (x1) 
 
1. Design 
Design workshop (x1) 
Benefit Options workshop (x1) 
Awareness Tools workshop (x1) 
4. Live Scheme 
Claim Submission 
Claim Decision 
Claim Payment 
3. Launching 
Selection of Officers 
Training of Officers 
Installation of MIS 
 
Baseline Research 
            Provider Survey           HH Survey          Qualitative: Healthcare 
        GPS & GIS Mapping                                 Qualitative: Social Capital 
4. Live Scheme
Claim Submission
Claim Decision
Claim Payment
3. Launching
Selection of Officers
Training of Officers
Installation of MIS
2. Awareness
Awareness Campaign (x3)
CHAT (x2)
Enrollment (x1)
Key Outcome Indicators 
Intensity of Usage of Health Services              Equity of Usage of Health Services       
Levels of Healthcare Expenditure              Socio-Economic Status of Household 
Accessibility of Healthcare 
Figure 2 CBHI Implementation & Research Processes.
Doyle et al. Trials 2011, 12:224
http://www.trialsjournal.com/content/12/1/224
Page 5 of 15aiming to secure community buy-in and scheme sustain-
ability. SHG leaders and scheme staff from the implement-
ing partner are taken through 3 structured workshops.
First, a Design workshop develops business processes for
operational aspects of CBHI (premium collection, claims
processing, etc.), integrating them into the existing NGO
and SHG management structures. Second, a Benefit
Options Finalisation workshop engages SHG leaders to
design up to 5 potential CBHI coverage packages. A sim-
ple MS-Excel interface allows participants to cost a profit-
neutral premium for any combination of coverage options
and caps, reflecting the prices and illness incidences
reported in a baseline survey (see below). Third, the same
audience is exposed to a range of pilot insurance educa-
tion tools (posters, songs, street plays, videos and a movie)
at an Awareness Tools workshop, and feedback gathered.
The “Awareness” module is then rolled out to the treat-
ment clusters. This module structures enrolment deci-
sions via a program of 6 fortnightly SHG meetings. The
first 3 discussions (“awareness campaign”)a r es t r u c t u r e d
educational sessions explaining the concept and workings
of insurance, intended for SHG members and the finan-
cial decision makers in their households. Two further
structured discussions introduce households to the avail-
able CBHI packages and ask each SHG to cast a vote for
one preferred package (“Choosing Healthplans All
Together” or CHAT). SHG votes are aggregated to
choose one insurance package for the trial. In one further
group meeting, the price and coverage of the selected
package are explained. Treatment group members can
enroll in CBHI at this meeting, or for a limited period
afterwards. Enrolment decisions are intended to be made
en-bloc: the members of each SHG must decide either to
join the insurance scheme as a group, along with all the
members of their households, or not enroll at all. En-bloc
enrollment helps to avoid adverse selection. Enrollment
decisions are voluntary, but necessarily public, as SHG
members must debate among themselves whether to join.
The simultaneous “Launching” module sets up back-
office and operations elements of the scheme. Processes
are formalised, and forms developed. Local variations in
specific processes are allowed. Five levels of staff are
elected from among SHG members and implementing
partner staff (local insurance activists, insurance coordina-
tor, claims committee, coordination committee, and
ombudsman). Multi-day trainings are held on-site for each
cadre of staff. A scheme office is set up at a focal point
within the project area, facilitated with phones and com-
puters. A dedicated microinsurance management informa-
tion system (MIS) application is delivered by MIA to the
implementing partner, and separate trainings on its use
are held.
Finally, once Awareness and Launching modules are
complete, the scheme goes live. Members are supplied
with pre-printed claim forms and printed materials
describing benefits. Insurance activists, present in all
clusters, assist CBHI members in submitting claims and
receiving payouts. All claims are transmitted to the
Claims Committee, composed of locally-elected leaders,
who meet monthly to decide on payouts. Successful
claims are paid in cash to the claimants. The separately
elected ombudsman mediates any disputes which arise
over claims decisions.
Objectives & outcome measures
The key objective of these trials is to examine the effect of
CBHI on members’ usage of healthcare services and
healthcare financing patterns. We put forward two pri-
mary hypotheses:
1. Members of a CBHI scheme will increase their
utilization of available healthcare, as compared to
those without insurance cover, for those categories
of treatment which are covered by the insurance
package.
2. Membership in a CBHI scheme is associated with a
decrease in the household’s Out-of-Pocket Spending
(OOPS) on healthcare, as compared to those without
insurance cover.
Two analogous primary outcome measures are used:
1. Number of consultations with a physician per case
of illness or injury
2. Net OOPS per case of illness or injury = Expendi-
ture on (Fees + cost of prescribed drugs + cost of
recommended tests + cost of other recommended
materials/procedures + insurance premium). OOPS
does not include, transport, accommodation, other
indirect costs of attaining healthcare, self-treatment,
costs reimbursed by insurance
A variety of additional measures will be used to help
assess healthcare usage in terms of the range of services
utilised by those seeking care. Beyond these areas of
core study, a rich set of quantitative, qualitative and spa-
tial data which is being collected will enable researchers
to examine secondary questions of the effect of CBHI
on households’ risk exposure, healthcare financing
methods, probability of catastrophic health expenditures,
consumption and investment patterns, and physical
accessibility of healthcare.
Method of Clustering
The first step in experimental design was to define the
units which would be used for randomisation. Building
from the smallest unit upwards, individuals, households,
SHGs and villages are not suitable: the first three provide
Doyle et al. Trials 2011, 12:224
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Page 6 of 15inaccurate analogues of the implementation environment
which would prevail in a non-experimental implementa-
tion; the fourth additionally causes research issues. Indi-
viduals and households a r eu n s u i t a b l eu n i t so f
randomisation because the treatment program is
designed to be administered to and managed by groups
of geographically proximate people with previous associa-
tions to each other. The SHG is an unsuitable unit
because villages typically contain multiple SHGs, and
members of control group SHGs with a strong preference
for insurance may push treatment group members to
include them. This may be difficult to resist within the
social structure of a small village. Implementing partners
further advised that randomisation at a sub-village level
would be perceived as capricious by the target popula-
tion, and would damage uptake rates. Villages are an
unsuitable unit of randomisation because SHG member-
ship levels are highly unbalanced over villages (Table 2):
the largest villages contain up to 18 times as many mem-
bers as the smallest. Randomising by village would open
the possibility of very small treatment groups in the first
wave, creating problems of statistical power, possibly
weakening implementation structures, and leaving the
insurance scheme more financially exposed to insolvency.
A group of villages is thus the smallest feasible clus-
ter/unit of randomisation. Researchers developed a tech-
nique to cluster villages together which explicitly
addresses the implementation constraints outlined above
i.e. communities must not be subdivided, clusters must
be geographically compact, and the insurance scheme
must have a roughly equal sized pool of potential mem-
bers whatever the outcome of randomisation. Baseline
records of number of household surveys completed by
SHG members were combined with GIS maps of the
implementation area to show the spatial distribution of
the trial population over villages (see Figure 3, panel 1
f o rt h em a pu s e da tK a n p u rD e h a t )‡. Three criteria
were then used to group villages into clusters:
￿ Non-Divisibility: A village cannot be divided over
different clusters.
￿ Equal Size: Clusters must contain (roughly) equal
numbers of SHG members. In interaction with the
non-divisibility criterion, this defines a target cluster
size, X:
X ≈ Highest No. Complete HH surveys at a Single Village
Note that the cluster size is defined as number of
baseline household surveys completed by SHG mem-
bers (rather than number of SHG members) as this
is the effective number of household-level observa-
tions per cluster.
￿ Continuity: Each cluster should be geographically
continuous. Where this is not possible, a cluster
must be formed from proximate villages, such that
no external village lies on a straight line between
any two villages in the cluster.
15, 17 and 16 clusters were defined at Pratapgarh, Kan-
pur Dehat and Vaishali respectively (see Figure 3, panel 2
for the configuration determined at Kanpur Dehat). Clus-
ters contain 60-80 households each (Table 2).
Power calculations
Sample size on these trials is pre-determined by the
number of persons meeting the inclusion criteria i.e. the
number of persons in households in which at least one
member has chosen to affiliate to an SHG. Researchers
have designed the trials to maximize their ability to
Table 2 Summary Research Statistics by Trial Sites
Trial 1 - Pratapgarh Trial 2 -
Kanpur Dehat
Trial 3 -
Vaishali
No. SHG Members 1557 1226 1459
No. Households
# 1455 1156 1454
No HH surveys complete 1284 1042 1363
No. Individuals
## 8933 7105 7838
Smallest village: Largest village 1:17 1:8 1:18
No. Villages 15 42 34
No. Clusters 15 17 16
Average HHs per cluster 86 61 84
Minimum Detectable Effect Size 0.406 0.397 0.394
# Estimate - As a HH may contain more than one SHG member, we do not know how many HHs are among the SHG members who did not answer surveys.
Estimate = [Counted number of households]+[(No of SHG members not answering a survey)*(1-proportion of households containing more than 1 SHG member
among HH survey respondents)]
## Estimate - Number of SHG members is known, but not all SHG members answered a HH survey, so size of all households is not known. Estimate = [(No. of
SHG members who did not answer HH survey) × (average HH size at site)] + [No. people in HHs of SHG members who answered HH survey]
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Page 7 of 15detect outcomes within the proscribed sample size.
Power calculations can provide a useful indication of the
probability that, given a certain study design, researchers
will be able to reject the hypothesis of zero effect when
an effect in fact exists. Using a priori information on
mean and variability of the outcomes of interest and the
correlation in these outcomes between households in
the same clusters, one can calculate, for a given study
 
 
 
 
 
 
 
 
 
 
 
3. Treatment 
and  
Control 
Clusters, 
Wave 1 
 
 
 
2. Clusters 
for 
Random 
Assignment 
 
 
 
1. Raw 
Distribution 
of  
SHG 
Members 
Figure 3 Illustration of Clustering and Randomisation Process at Trial 2 (Kanpur Dehat). In panel 1, each coloured and bounded area is
one village. In Panel 2, villages marked in the same colour and with the same number, form a cluster.
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Page 8 of 15design, the minimum detectable effect size (MDES) of
the study. The standardised MDES for an outcome of
interest, y, given a study design that has J clusters of
identical size n, and a proportion P of the sample that is
considered treated, can be calculated as [7]:
MDESy =
tα/2 + t1−κ 
P(1 − P)J

ρ +
1 − ρ
n
where r is the correlation in y between households in
t h es a m ec l u s t e r , represents the probability that we
reject the null hypothesis of no effect when it is in fact
false (power), a is the significance level and ta/2 and t1-
are given by t-tables. This equation illustrates that the
MDES is very dependent on the number of clusters (J),
while cluster size (n) affects MDES much less; especially
when households within clusters are quite similar (r is
large). In sum, when individuals in clusters are very alike,
having more clusters is preferred to having more people
within clusters [20]. However, creating clusters smaller
than groups of villages complicates the implementation
of the CBHI scheme. Therefore several negotiation
rounds have taken place between implementing and
research partners to get to a study design that is workable
for both parties. The following conservative assumptions
have been made in our power calculations, which were
done using the Optimal Design 1.77 :
￿ a = 0.05 - Type I error rate of 5%
￿  = 0.80 - Power of 80%
￿ r =0 . 0 5- Intra-cluster correlation (ICC) of 5%.
This estimate was chosen to be conservative with
regards to empirical experience on the most similar
previous trial [21], and also with regards to our own
baseline data**.
￿ n = 60-80 - see Table 2 for the average cluster size
by site
￿ J = 15-17 - see Table 2 for the number of clusters
per site
The parameters used implicitly assume that evaluation
is undertaken at a household level. For variables mea-
sured at the individual level, power is higher due to the
increased number of observations per cluster. The result-
ing standardised MDES were calculated at 0.39-0.40,
meaning that our experiment allows picking up an effect
of the magnitude of 0.39-0.40 times the standard devia-
tion of the variable of interest (see Table 2).
Method of Randomisation
The final step in study design is to determine the process
which will assign clusters to either the treatment or con-
trol group. Random assignment of clusters is the method
most likely to ensure there are no systematic differences
between the two groups. Prior to randomisation, it was
evident that the trials would inevitably take place in an
unblinded environment, i.e. both treatment and control
group members would be aware of their status (as would
researchers and implementers). For any configuration of
clusters, villages in the treatment and control clusters are
proximate to each other and social, familial, business and
political linkages can exist across them. Knowledge of
CBHI will inevitably become available to the control
population. Unblinded trials can contain risks of bias - of
particular concern was the risk that control population
members with a strong preference for inclusion in the
CBHI program would push scheme administrators to
register them, or change their health care seeking beha-
viour/answers during data collection because of their
awareness of the insurance schemes [22]. Moreover, ethi-
cal concerns were expressed by implementers about pre-
cluding members from access to a potentially beneficial
program (this is a common justification for stepped-
wedge randomisation [23]). To forestall the risk of bias of
results, and assuage ethical concerns, it was decided to
assign treatment on a “stepped-wedge” basis [24]. Three
waves of treatment will be undertaken, with one third of
clusters randomly assigned for treatment in each wave.
By the end of the project, all clusters will receive treat-
ment. Prior to wave 1, it was publicly announced that all
villages would be included in the scheme, but that imple-
mentation would be gradual.
Pre-randomisation matching of clusters was considered,
in order to improve balance on important observable char-
acteristics between treated and controls groups. As there
are few clusters and many variables we would like to
match on, we employed a method for reducing the dimen-
sionality of the matching characteristics, similar to propen-
sity score matching techniques [25]. For each site, a probit
regression was run at the household level, with a binary
indicator of any healthcare use in the last one month as
dependent variable, against a variety of socioeconomic,
health and demographic variables
†† . Data was taken from
the baseline survey (see section 3.4.1). The linear predic-
tions from this probit model were then used to rank clus-
ters: clusters with similar predicted outcome values can be
expected to have broadly similar values of the determinants
of health care use. The top three ranked clusters were
matched into one triplet, the next three into a second tri-
plet and so on. Within each triplet, one cluster is then ran-
domly assigned to the first treatment wave, one to the
second and one to the third. In this manner, we ensure
that clusters in the three groups are likely to be similar in
the matching variable, and therefore also likely to have
similar observable characteristics.
Table 3 and Table 4 show means of selected variables
for treatment and control groups (for wave 1)
†† generated
using a simple random draw and the matching procedure
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these studies are related to health care use, supply of
health care and health status (see section 4.5), it is espe-
cially important to achieve balance on these variables.
Generally there are few significant differences in observa-
ble characteristics between treatment and control groups
across the three sites, with the exception of variables
related to health care supply (especially in Pratapgarh),
and religion/caste. Matching induces little improvement
in balancing as compared to simple randomisation, and
given the decrease in power that typically results from
using a matching design with limited clusters numbers
[26], research staff used a simple random draw (utilizing
the sample routine available in Stata 11) to define the
order in which clusters were offered CBHI at Kanpur
Dehat and Vaishali (see Figure 3, panel 3 for randomisa-
tion at Kanpur Dehat).
This random draw procedure was modified for Pratap-
garh, which has a small number of villages (15) and
highly varying numbers of SHG members per village.
This situation makes it impossible to define clusters of
villages as described in section above. Therefore, at Pra-
tapgarh, we created 5 triplets of 3 villages each, by rank-
ing villages according to the number of SHG members
within each village, then placing the three largest in one
triplet, and so on. In each triplet of villages, one village
was then randomly assigned to each of the three treat-
ment waves. This procedure is expected to involve a
smaller loss of power than pure matching, due to the
smaller number of degrees of freedom taken up [27].
Outcome Measures & Data Collection
These trials follow a mixed methods design, collecting
quantitative, qualitative and spatial data on trial impact.
The quantitative outcome indicators being tracked offer
a holistic coverage of the key impact areas in CBHI:
health services utilisation levels, healthcare expenditure
and financing patterns, equity in healthcare use, and
households’ socio-economic status. Parallel programs of
spatial and qualitative research provide complimentary
Table 3 Means of selected covariates across treatment and controls (in wave 1)
Random draw
Kanpur Dehat Pratapgarh Vaishali
treated control p-value treated control p-value treated control p-value
Female (1/0) 0.48 0.49 0.22 0.52 0.53 0.27 0.53 0.52 0.52
Education (years) 4.83 4.95 0.48 4.30 4.30 0.97 3.34 3.08 0.07
Middle wealth third
† (1/0) 0.35 0.35 0.90 0.40 0.31 0.00 0.27 0.38 0.00
Highest wealth third
† (1/0) 0.37 0.34 0.33 0.29 0.33 0.10 0.34 0.30 0.22
Scheduled Tribe (1/0) 0.04 0.06 0.08 0.02 0.04 0.11 0.03 0.01 0.01
Scheduled Caste(1/0) 0.24 0.19 0.05 0.34 0.34 0.83 0.36 0.28 0.00
Other backward caste(1/0) 0.50 0.54 0.22 0.44 0.41 0.37 0.51 0.63 0.00
General Caste (1/0) 0.14 0.13 0.78 0.07 0.09 0.17 0.07 0.03 0.00
Nomadic Tribe (1/0) 0.09 0.08 0.64 0.13 0.12 0.33 0.03 0.05 0.04
age 0-5 years (1/0) 0.11 0.11 0.82 0.12 0.11 0.19 0.15 0.16 0.28
age 5-18 years (1/0) 0.35 0.35 0.74 0.37 0.37 0.97 0.35 0.35 0.55
age 50 years and older (1/0)s 0.14 0.14 0.65 0.16 0.16 0.64 0.13 0.13 0.64
reporting excellent or good health (1/0) 0.60 0.61 0.46 0.59 0.60 0.16 0.48 0.50 0.16
number of acute illness in last 30 days 1.35 1.37 0.85 1.18 1.10 0.21 1.12 1.00 0.02
self employed agriculture (1/0) 0.23 0.19 0.00 0.07 0.07 0.56 0.08 0.07 0.63
self employed business (1/0) 0.03 0.03 0.80 0.04 0.06 0.02 0.06 0.06 0.81
not working (1/0) 0.46 0.49 0.03 0.55 0.53 0.07 0.53 0.53 0.88
Salaried worker (1/0) 0.02 0.02 0.52 0.02 0.03 0.14 0.01 0.01 0.54
occasional salary (1/0) 0.05 0.05 0.38 0.11 0.11 0.89 0.12 0.12 0.81
number of chronic illness in last 30 days 0.73 0.84 0.07 1.44 1.31 0.04 0.71 0.80 0.09
inpatient facility within 30 min (1/0) 0.15 0.24 0.00 0.58 0.55 0.31 0.75 0.75 0.83
outpatient facility within 15 min (1/0) 0.38 0.45 0.01 0.52 0.51 0.77 0.56 0.69 0.00
pharmacy within 15 min (1/0) 0.36 0.45 0.00 0.52 0.51 0.77 0.53 0.63 0.00
minimum time to a health facility (minutes) 23.21 20.41 0.04 16.82 15.88 0.10 14.58 12.36 0.00
not got care when needed (1/0) 0.17 0.16 0.76 0.22 0.23 0.59 0.18 0.19 0.69
A simple random draw is used to draw 3 equally sized groups of clusters.
† Information on asset ownership and housing characteristics were combined to estimate a wealth index using principal component analysis and divide the population
in wealth thirds [39]
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impact areas which are not amenable to purely quantita-
tive analysis (e.g. social capital, or physical access to
care). This section describes all tools used for data col-
lection. These will be administered in all 3 waves over
the course of the study, with each research wave being
undertaken immediately prior to a wave of implementa-
tion. A longitudinal database is thus built up in each
research strand, allowing evaluators to map the evolu-
tion of the impact of insurance over time. All tools were
drafted with input from a scientific advisory committee
and researchers with prior field surveying experience on
related topics. Ethical approval for all tools was gained
from the independent ethics committee of the Univer-
sity of Cologne. Informed consent was taken prior to
each interview, and respondents were free to halt the
interview at any time, or to refuse to answer questions
within it. All baseline surveying took place prior to the
release of information about the CBHI project to the
community, such that the baseline data is not biased by
knowledge of the experiment.
Quantitative data collection
The core quantitative tool is a Household (HH) survey.
This survey covers a standard set of demographic vari-
ables, along with brief self-reports of health status (drawn
from the EQ-5D tool) and a vulnerability module [28]
§§ .
Core sections record illness-level data on health-seeking
behaviour, expenditure levels and financing methods. The
survey contains an exceptional amount of detail on health
care seeking behavior and financing, as these are the main
topics of study, but also because detailed information on
frequency of visits and associated costs is needed for the
calculation of insurance premia. HH socio-economic sta-
tus is captured via questions on monthly non-health
expenditures and asset ownership, similar to the formats
used by the Indian government’s National Sample Survey
Organisation.
Baseline data collection took place from March to May
2010. The tool was administered to all households in
both treatment and control groups, with either the SHG
member or the head of household as the primary respon-
dent. A separate, additional sampling frame of non-SHG
Table 4 Means of selected covariates across treatment and controls (in wave 1)
Random draw with matching
Kanpur Dehat Pratapgarh Vaishali
treated control p-value treated control p-value treated control p-value
female 0.47 0.49 0.06 0.52 0.53 0.37 0.53 0.52 0.62
education year 4.89 4.91 0.86 4.49 4.22 0.05 3.58 2.97 0.00
middle asset third 0.36 0.34 0.63 0.32 0.35 0.23 0.29 0.37 0.01
highest asset third 0.38 0.33 0.09 0.37 0.29 0.00 0.39 0.28 0.00
Scheduled Tribe (1/0) 0.03 0.07 0.00 0.04 0.03 0.67 0.02 0.02 0.70
Scheduled Caste(1/0) 0.21 0.21 0.97 0.43 0.30 0.00 0.24 0.33 0.00
Other backward caste(1/0) 0.61 0.47 0.00 0.37 0.45 0.00 0.60 0.59 0.93
General Caste (1/0) 0.08 0.17 0.00 0.06 0.09 0.09 0.06 0.03 0.01
Nomadic Tribe (1/0) 0.08 0.08 0.78 0.11 0.13 0.40 0.08 0.03 0.00
age 0-5 years (1/0) 0.10 0.11 0.44 0.12 0.11 0.92 0.15 0.16 0.15
age 5-18 years (1/0) 0.36 0.34 0.28 0.37 0.36 0.78 0.35 0.35 0.57
age 50 years and older (1/0)s 0.13 0.14 0.50 0.16 0.16 0.54 0.13 0.13 0.91
reporting excellent or good health (1/0) 0.60 0.61 0.61 0.61 0.59 0.37 0.50 0.49 0.31
number of acute illness in last 30 days 1.41 1.33 0.26 1.21 1.10 0.11 1.08 1.02 0.27
self employed agriculture (1/0) 0.23 0.19 0.00 0.07 0.07 0.79 0.07 0.08 0.44
self employed business (1/0) 0.03 0.03 0.94 0.06 0.05 0.05 0.07 0.06 0.05
not working (1/0) 0.47 0.48 0.49 0.52 0.54 0.15 0.53 0.53 0.84
Salaried worker (1/0) 0.02 0.02 0.51 0.03 0.02 0.01 0.01 0.01 0.07
occasional salary (1/0) 0.05 0.06 0.20 0.10 0.11 0.53 0.10 0.12 0.09
number of chronic illness in last 30 days 0.76 0.82 0.30 1.32 1.37 0.40 0.77 0.77 0.96
inpatient facility within 30 min (1/0) 0.18 0.22 0.18 0.53 0.58 0.09 0.76 0.74 0.63
outpatient facility within 15 min (1/0) 0.38 0.45 0.02 0.59 0.48 0.00 0.62 0.66 0.10
pharmacy within 15 min (1/0) 0.44 0.40 0.22 0.66 0.44 0.00 0.60 0.60 0.89
minimum time to a health facility (minutes) 20.39 22.11 0.22 14.13 17.13 0.00 13.22 13.00 0.73
not got care when needed (1/0) 0.02 -0.10 0.47 0.21 0.23 0.36 0.19 0.19 0.95
female autonomy index 1772.50 1577.70 0.48 0.25 -0.17 0.01 -0.18 -0.01 0.22
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each site, and 1500 non-SHG households selected for
interview, via a random draw, using village population to
weight interview numbers per village. Research staff
remained on site throughout data collection, supervising
widespread random spot-checks of completed forms.
Completed forms were entered into a relational database
via a customised CS-Pro based interface. Electronic data
was again randomly re-checked against original physical
forms. 3,686 SHG households were interviewed and
1,562 non-SHG households. The overall response rate
among SHG members was 87%, as some households con-
tained more than one SHG member, and some were not
available at the time of interview. The response rate
among non-SHG members was 100%, as unlike SHG
members, non-responding households were replaced
with an alternate household.
Qualitative data collection
A parallel program of qualitative research explores similar
key areas. This research stream examines some areas not
amenable to other forms of research e.g. social capital. It
also serves to identify knowledge gaps to be filled by other
methods; to probe and explain contextual differences in
relationships identified by quantitative investigation; to
provide comparative and/or corroborative evidence for
quantitative conclusions and interpretative data in case of
failures; and to detect unexpected side-effects. Research is
divided into two strands: Health Issues and Social Capital
& Risk Management. Health Issues covers understanding
of health problems, healthcare seeking behaviour, and pat-
terns of healthcare expenditure. Social Capital & Risk
Management includes types of risk experienced, coping
mechanisms, healthcare financing mechanisms, insurance
knowledge, and community dynamics.
Both sets of topics are examined via semi-structured
focus group discussions (FGDs) and key informant
interviews (KIIs). FGDs are held with the SHG members
and male head of the SHG households. Key-informant
interviews are administered individually to healthcare
providers, SHG leaders and community leaders. A sepa-
rate version of each tool is used depending on type/cate-
gory of respondent. To select respondents, SHG groups
are stratified into three categories according to their dis-
tance from modern healthcare, and equal numbers of
groups are then selected randomly selected from each
category, allowing researchers to capture the range of
conditions across the study area. Research staff
remained on site throughout data collection, providing
extensive field supervision and feedback to the field
investigators. 104 FGDs and 91 KIIs for health issues
were completed across all three sites during baseline. 72
FGDs and 18 KIIs on social capital and risk protection
were completed.
Spatial data collection
Baseline spatial surveying took place from May-June
2010. At each site, village boundaries and road networks
were mapped with the aid of GIS, and locations of all
healthcare providers were recorded via handheld Global
Positioning System (GPS) recorders. Once mapped, a
quantitative health care provider (HCP) questionnaire
was administered to the manager or senior medic at each
provider. The HCP questionnaire catalogues services pro-
vided, facilities available, staffing levels and prices of each
provider. The questionnaire was administered to all
healthcare providers located in the block (a medium-
sized Government of India administrative region) in
which the projects are taking place, along with secondary
and tertiary providers located in close proximity to the
block. All forms of providers are covered, including
unqualified providers of modern healthcare, traditional
healers and spiritual healers.
All data collection was performed under field supervi-
sion from research staff, and all forms back-checked in
situ. GPS data was uploaded at regular intervals to track
its collection and accuracy. Post-survey, HCP data was
double-entered via a customised Microsoft Access format.
Detailed GIS maps depicting village boundaries, road net-
works and provider locations were developed, and HCP
data was joined with the GIS maps. 3092 HCP surveys
were completed.
Process evaluations
On these trials, a long set of activities link the baseline
and outcome levels of key impact indicators. A range of
associated assumptions as to how the implementation
program runs, and the outcome each module generates,
underlies the causality asserted by researchers. A “plausi-
bility”[29] or “theory-based”[30] approach, in which the
underlying causal chain assumed by the trial is explicitly
outlined and empirically tested, is widely suggested as a
necessary support to the validity of impact evaluations of
such programs. Including such “process” evaluations as
an integral part of trial design has been suggested as par-
ticularly helpful in multi-site cluster randomised trials of
programs, where identical/highly similar interventions
may be managed or received differently by different audi-
ences [31]. Therefore, in addition to baseline tools, quali-
tative and quantitative interventions examining the
operation of key elements in the treatment process will
be implemented.
Discussion
Relationship to other trials
The treatment program on these three trials randomises
access to insurance cover; three previous trials which ran-
domise access to micro health insurance have been under-
taken, one in Africa [10], one in Latin America [32], and
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these trials apply a program of community action: the
treatment population is enjoined in group settings to learn
about insurance, before actively making community deci-
sions regarding the content, form, and management of the
insurance scheme. The response to treatment is not purely
reactive, but interactive. A recent strand of literature has
seen CRCTs which randomise participation in structured,
interactive programs of participatory community action
being developed [34] and conducted [35]. At least one pre-
vious study has combined two of these elements (access to
a microfinance product, and a participatory community
training and action cycle) into a single treatment program
[36,37]. It should be noted that while the treatment
applied is thematically related to those used in other trials,
the overall treatment effect should not be considered as a
sum of these parts: the treatment applied in this study is a
program, whose effects must be evaluated as a whole [19].
External validity of trials
CRCTs provide sound quantitative information on the
causal effects of an intervention on the outcome measures
of interest. However, no randomised trial generates results
which are applicable to all persons in all settings [38]. The
limits on the external validity and generalisability of find-
ings on these trials are defined by the two stages of selec-
tion prior to randomisation: the purposive selection of
implementing partners, and the self-selection of local resi-
dents into implementing partners’ SHG ground structure.
Both stages of selection are necessary to establish the con-
ditions required for implementation of this program. It
should be made explicit that our experiments will only
allow statements on the impact of CBHI on access to care
and financial protection within a population of SHGs.
Researchers have thus taken steps to ensure that the limits
of external validity of the trials can be probed. All quanti-
tative elements of the baseline study were applied to sepa-
rately selected samples of SHG and non-SHG population
in the trial areas, allowing researchers to map in detail
observed differences between the two groups. Additionally,
the treatment program is replicated in three separate set-
tings, with three almost entirely separate implementation
teams. This affords researchers greater confidence in dis-
cerning results that are potentially generalisable, by allow-
ing them to search for results which are repeated over
trials. Social science RCTs typically run only one trial: in
this context, three replications is a considerable advance
for external validity.
The only aspect of the institutional environment which
has been purposively varied by site is the average length of
operation of SHGs. At site 1, most SHGs have been in
existence for over a decade. At site 3, most SHGs were
specially created for the purposes of the insurance trial,
and were in operation for only 9-12 months prior to the
beginning of CBHI activities. Trial 2 has average SHG
operating lengths of 4-6 years. This variation allows insight
into the depth of community involvement necessary to
produce effective implementations.
Conclusion
In this paper, we have described the design of three trials
which must randomise access to an insurance scheme
within a pre-existing community, but also aim to set up
insurance administration structures based on social lin-
kages between treatment group members. We point out
several dangers to the validity and accuracy of the mea-
sured outcomes of these trials. Of particular concern is
that randomisation across community lines can lower
treatment uptake, and create conditions that encourage
contamination of the control group. These dangers are
caused because of the fact that the treatment program
must be run as a trial.
In order to avoid these dangers, we have made a unique
package of research design decisions. Of particular note is
an innovative approach to defining the clusters/units of
randomisation used in the trial, which aims to preserve
community structures within each cluster as far as possi-
ble; this is allied to the infrequently used “step-wedge” ran-
domisation design to dis-incentivise control group
members from pushing for inclusion in the scheme.
Two lessons can be drawn, one narrow, and one more
general. Narrowly, trials which must subdivide within a
community, but seek to preserve community structures,
may find that the design described here, or a variant
thereof, will serve to increase the robustness of their out-
put. More broadly, this paper can be read as a case study
of how the research demands of a randomised trial of a
social program have the potential to alter the environment
in which the program is implemented. This in turn can
alter the impact of the program: so what is measured by
the experiment is not what would have occurred if the
program had been run non-experimentally. This is a little
discussed, but no doubt often encountered issue in the
design of randomised trials in the social sciences.
Researchers must take care to identify and make their
trials robust to these potential feedbacks.
Endnotes
*Note that in the context of voluntary insurance, self-
selection of households into the CBHI scheme still exists.
For this reason, it is important to compare those initially
assigned to the treatment group to those in the control
group, independent of insurance status and measure the
intention to treat effect. Longitudinal data collection also
offers possibilities to control for selection into the insur-
ance scheme.
† Note that this purposive selection was used to
increase the probability of successful uptake of the
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Page 13 of 15CBHI schemes, but also means that measures of impact
are not necessarily generalisable to the entire Indian
SHG population.
‡Experimental design took place immediately after
baseline surveying was completed
§Available from www.wtgrantfoundation.org/resources/
overview/research_tools.The Cluster Randomised Trials
with Repeated Measures module was used, which
employs a considerably more complex version of the
basic formula presented in the text. Within this more
complex formulation we additionally set the parameters
F (frequency of surveying) = 1, D (trial duration) = 2. P
is not a required parameter.
**ICC was found to be less than 5% for most variables
of interest in baseline data (calculated using Stata’s lone-
way routine). This implies lower MDESs than those
presented.
†† To avoid having to impose a dependent variable,
which obviously affects the weight that is given to each of
the variables in creating the matching variable, we also
tried using principal component analysis. Results were
qualitatively similar, but we prefer using a regression
based approach as this has the advantage that the covari-
ates that are highly correlated with the probability to use
health care, and therefore important to achieve balance
on, get a larger ‘weight’ in the matching variable.
‡‡Note that we define treated as those offered CBHI in
the first wave, and controls as those treated at any point
after the first wave.
§§More information on vulnerability survey scan be
found at http://go.worldbank.org/R048B34JF0
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